ORLANDO — Combining an enzyme-inducing antiseizure medication with a direct-acting oral anticoagulant (DOAC) does not significantly increase the risk of thromboembolic events in patients with epilepsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results